Ryan Douglas: FDA approves Digital Therapeutics SDK

Ryan Douglas is the co-founder of DeepWell DTx, a digital therapeutics venture lab dedicated to creating immersive experiences that address mental health challenges.

Recently, DeepWell DTx achieved a major milestone: the U.S. Food and Drug Administration cleared five mental health apps, including DeepWell's software development kit (SDK). This marks the first time digital therapeutics have been approved for medical use, paving the way for games to be reimbursed through medical insurance.